Venture capital deal-making in the U.S. declined in the fourth quarter of 2019, but biotechnology start-ups remained the most sought-after investment targets of any sector. . . . → Read More: Venture Deals, Dollars Fall in Q4 2019; Biotech Stays Hot
|
|||||
|
|
UPMC, the medical center affiliated with University of Pittsburgh, plans to invest $1 billion in life science advances, with spin-off companies as part of its strategy. . . . → Read More: UPMC to Invest $1 Billion in Medical Enterprises 
A biotechnology company launched yesterday that plans to discover and develop therapies faster and at lower cost than many of today’s new drugs. . . . → Read More: New Biotech Aims to Bring Down Drug Prices 
A company designing vaccines delivered with a microneedle patch to prevent infectious diseases is raising $11 million in its first venture funding round. . . . → Read More: Vaccine Developer Gains $11M in Early Funds 
Since October, the Nasdaq Biotechnology Index rose steadily to a new high for the year, as shown in this weekend’s infographic. . . . → Read More: Infographic – Biotech Index Zooms to New High 
A biotechnology company creating synthetic proteins that invoke the immune system to fight cancer is being acquired by drug maker Astellas Pharma. . . . → Read More: Synthetic Bio Cancer Immunotherapy Company Acquired  Comments are closed  Finance  Asia, biomedical, biotechnology, cancer, equity, investment, Japan, life sciences, merger, pharmaceuticals 
A company making gloves that transmit a sense of touch in games and commercial robotics is raising $12 million in its first venture funding round. . . . → Read More: Touch Sensor Developer Gains $12M in Early Funds Comments are closed Finance, Joint ventures/collaborations computer science, engineering, equity, investment, physical sciences, robotics, software, venture capital 
A biotechnology company developing cancer immunotherapies with synthetic viruses is licensing its technology to Takeda Pharmaceuticals. . . . → Read More: Engineered Viruses Licensed for Cancer Therapies One comment - (Comments are closed) Intellectual property, Joint ventures/collaborations biomedical, biotechnology, Canada, cancer, entrepreneurs, equity, licensing, life sciences, pharmaceuticals, university 
A company developing protein-like therapies for cancer from synthetic bacteria is being acquired by drug maker Sanofi in a deal valued at $2.35 billion. . . . → Read More: Synthetic Bio Company Acquired in $2.35B Deal Comments are closed Finance biomedical, biotechnology, cancer, chemistry, clinical trials, entrepreneurs, equity, genomics, life sciences, merger, pharmaceuticals, physical sciences 
A start-up company developing systems with artificial intelligence to aid the work of radiologists is raising $4 million in its seed funding round. . . . → Read More: Radiology A.I. Company Raises $4M in Seed Funds Comments are closed Finance biomedical, engineering, entrepreneurs, equity, investment, life sciences, mathematics, medical device, physical sciences, software, venture capital |
||||
|
Copyright © 2020 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||